Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 306

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Have we evaluated addiction treatment correctly? Implications from a chronic care perspective

Open access
McLellan, A. Thomas·2002·Addiction

Abstract

The excellent reviews of alcohol treatment outcomes and methods for evaluating and comparing treatment outcomes (Moyer, Finney & Swearingen 2002a; Moyer et al. 2002b; Miller & Wilbourne 2002) provide ample evidence of the methodological rigor and technological sophistication that have been developed in this field over the past 30 years. At the same time, these reviews have led me to question the conceptual underpinnings of addiction treatment and with it, addiction treatment outcome evaluation. In this regard, I have become interested in the analogies between addiction—both alcohol and drug addiction—and other chronic medical illnesses such as diabetes, hypertension and asthma (see O’Brien & McLellan 1996; McLellan et al. 2000). Literature reviews of treatment adherence and treatment relapse rates yielded rather surprising similarities between addictive disorders and these three, well-characterized chronic medical illnesses (see McLellan et al. 2000). For example, in virtually all cases where patients have been prescribed medications for these chronic illnesses, less than 50% continue to take those medications as prescribed; less than 30% of patients comply with prescribed behavioral changes such as weight loss, dietary restrictions on sugars or cholesterol or exercise regimens. When ‘relapse’ is defined as the re-emergence of symptoms requiring treatment in a hospital or an emergency room, the published studies suggest that 40–60% of patients with hypertension, diabetes or asthma relapse every year (see McLellan et al. 2000). It is important to note that all cases of addiction are not chronic. Many who meet diagnostic criteria for substance dependence recover completely, even without treatment. Others have long remissions following treatment. However, many of those who develop addiction disorders suffer multiple relapses following treatments and are thought to retain a continuing vulnerability to relapse for years or perhaps a lifetime. In this paper, I will continue the analogy between addiction and chronic medical illnesses, but not to further the debate on whether addiction really is a ‘disease’. Here, I focus on the separate—and I think under-appreciated question—of whether the assumptions underlying interventions for acute conditions or those for chronic conditions are more appropriate for the treatment addiction. Without any conclusion regarding the essence of addiction—a medical problem, a sin or a learned behavior—I offer two provocative implications that derive from thinking about addiction as a chronic condition. Any examination of the published effectiveness of treatments for chronic illnesses leads to the question of why they are considered to be so successful by the public at large. One answer is illustrated in Fig. 1. This figure shows the results of a typical trial of a new medication or a new intervention in the treatment of any chronic illness (the example here is hypertension). Severity of primary symptoms, blood pressure in this example, is measured along the y-axis. Pictured on the x-axis are measurement points prior to the start of treatment, three times during the course of the treatment and following the patient’s discontinuation of treatment. Evaluation of a hypothetical hypertension treatment. The effectiveness of the treatment evaluated in this hypothetical study is obvious. The first sign of effectiveness is the reduction in symptoms from before to during treatment. Although this treatment did not eliminate symptoms, there was a 75% improvement for the patient. There is a second way that the medical community and the public at large see effectiveness in this example: the re-emergence of symptoms following discontinuation of the treatment. Importantly, there is no expectation of cure in this evaluation: only that an effective treatment will reduce symptom severity while it is being administered. Indeed, the re-emergence of symptoms following discontinuation of a treatment has been used as a justification for strategies to retain patients in treatment. Consider a similar evaluation (Fig. 2), duplicating exactly the earlier results, except that it is the evaluation of an addiction treatment. The y-axis again shows symptom severity, perhaps days of cocaine use or number of standard drinks of alcohol in the past week. The x-axis shows the same measurement points. Here again, researchers, treatment providers and policy makers would all agree that the treatment was obviously not effective. Why? Because almost all addiction treatments (methadone maintenance and AA may be the only exceptions) are expected to produce lasting reduction in symptoms following termination of treatment. The reduction of symptoms during treatment is not adequate to the expectations underlying addiction treatment. In turn, almost all treatments have been evaluated six or 12 months following discharge from those treatments. From this perspective, the ‘disappointing’ return of symptoms following treatment discharge

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1360-0443.2002.00127.x

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 15 references

Research works printed but not linked: 2

  1. 10.1037/0003-066X.41.7.794 · doi:10.1037/0003-066x.41.7.794 · Paper page
  2. Weisner C., 1997, Indicators of Chronic Health Conditions: Monitoring Community‐Level Delivery Systems, 260

Cited by

See all 306

Metadata

Authors
McLellan, A. T.
Venue
Addiction
Publisher
Wiley
Published
2002-03
Volume
97
Issue
3
Pages
249-252
ISSN
  • 0965-2140 (ISSN-L)
  • 1360-0443
OpenAlex
W2137361412
Cited by
306
References
15
FWCI
6.65
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. https://app.cochat.ai/papers/10.1046/j.1360-0443.2002.00127.x
The paper
McLellan, A. T. (2002). Have we evaluated addiction treatment correctly? Implications from a chronic care perspective. Addiction. https://doi.org/10.1046/j.1360-0443.2002.00127.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.